400 related articles for article (PubMed ID: 27900630)
1. Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons.
Maciver AH; Al-Sukhni E; Esquivel J; Skitzki JJ; Kane JM; Francescutti VA
Ann Surg Oncol; 2017 Apr; 24(4):923-930. PubMed ID: 27900630
[TBL] [Abstract][Full Text] [Related]
2. Best practice for perioperative management of patients with cytoreductive surgery and HIPEC.
Raspé C; Flöther L; Schneider R; Bucher M; Piso P
Eur J Surg Oncol; 2017 Jun; 43(6):1013-1027. PubMed ID: 27727026
[TBL] [Abstract][Full Text] [Related]
3. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
Morales-Soriano R; Esteve-Pérez N; Segura-Sampedro JJ; Cascales-Campos P; Barrios P;
Eur J Surg Oncol; 2018 Feb; 44(2):228-236. PubMed ID: 29242018
[TBL] [Abstract][Full Text] [Related]
4. Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons.
Yoo HJ; Hong JJ; Ko YB; Lee M; Kim Y; Han HY; Song YJ; Lim MC; Park SY
World J Surg Oncol; 2018 May; 16(1):92. PubMed ID: 29764445
[TBL] [Abstract][Full Text] [Related]
5. Epidural analgesia combined with a comprehensive physiotherapy program after Cytoreductive Surgery and HIPEC is associated with enhanced post-operative recovery and reduces intensive care unit stay: A retrospective study of 124 patients.
Osseis M; Weyrech J; Gayat E; Dagois S; Lo Dico R; Pocard M; Eveno C
Eur J Surg Oncol; 2016 Dec; 42(12):1938-1943. PubMed ID: 27381171
[TBL] [Abstract][Full Text] [Related]
6. Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey.
Ferron G; Simon L; Guyon F; Glehen O; Goere D; Elias D; Pocard M; Gladieff L; Bereder JM; Brigand C; Classe JM; Guilloit JM; Quenet F; Abboud K; Arvieux C; Bibeau F; De Chaisemartin C; Delroeux D; Durand-Fontanier S; Goasguen N; Gouthi L; Heyd B; Kianmanesh R; Leblanc E; Loi V; Lorimier G; Marchal F; Mariani P; Mariette C; Meeus P; Msika S; Ortega-Deballon P; Paineau J; Pezet D; Piessen G; Pirro N; Pomel C; Porcheron J; Pourcher G; Rat P; Regimbeau JM; Sabbagh C; Thibaudeau E; Torrent JJ; Tougeron D; Tuech JJ; Zinzindohoue F; Lundberg P; Herin F; Villeneuve L;
Eur J Surg Oncol; 2015 Oct; 41(10):1361-7. PubMed ID: 26263848
[TBL] [Abstract][Full Text] [Related]
7. Current practice of Latin American centers in the treatment of peritoneal diseases with cytoreductive surgery with HIPEC.
Latin American Registry of Peritoneal Diseases – LARPD participants
Eur J Surg Oncol; 2018 Nov; 44(11):1800-1804. PubMed ID: 30037640
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
[TBL] [Abstract][Full Text] [Related]
9. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).
Bushati M; Rovers KP; Sommariva A; Sugarbaker PH; Morris DL; Yonemura Y; Quadros CA; Somashekhar SP; Ceelen W; Dubé P; Li Y; Verwaal VJ; Glehen O; Piso P; Spiliotis J; Teo MCC; González-Moreno S; Cashin PH; Lehmann K; Deraco M; Moran B; de Hingh IHJT
Eur J Surg Oncol; 2018 Dec; 44(12):1942-1948. PubMed ID: 30075978
[TBL] [Abstract][Full Text] [Related]
10. Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience.
Bell JC; Rylah BG; Chambers RW; Peet H; Mohamed F; Moran BJ
Ann Surg Oncol; 2012 Dec; 19(13):4244-51. PubMed ID: 22805865
[TBL] [Abstract][Full Text] [Related]
11. High-quality results of cytoreductive surgery and heated intraperitoneal chemotherapy perfusion for carcinomatosis at a low volume institution.
Bommareddi SR; Simianu VV; Mann LV; Mann GN
J Surg Oncol; 2015 Aug; 112(2):219-24. PubMed ID: 26274508
[TBL] [Abstract][Full Text] [Related]
12. Knowledge, attitudes and practice of surgeons regarding nutritional support in CRS and HIPEC patients: Are we missing something?
Naffouje SA; De La Cruz K; Berard D; Guy S; Salti GI
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12930. PubMed ID: 30298962
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management.
Hübner M; Kusamura S; Villeneuve L; Al-Niaimi A; Alyami M; Balonov K; Bell J; Bristow R; Guiral DC; Fagotti A; Falcão LFR; Glehen O; Lambert L; Mack L; Muenster T; Piso P; Pocard M; Rau B; Sgarbura O; Somashekhar SP; Wadhwa A; Altman A; Fawcett W; Veerapong J; Nelson G
Eur J Surg Oncol; 2020 Dec; 46(12):2292-2310. PubMed ID: 32873454
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study.
Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S475-82. PubMed ID: 21837528
[TBL] [Abstract][Full Text] [Related]
15. Current practices and barriers to referral for cytoreductive surgery and HIPEC among colorectal surgeons: A binational survey.
Siddiqui J; Brown K; Zahid A; Young CJ
Eur J Surg Oncol; 2020 Jan; 46(1):166-172. PubMed ID: 31542240
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal Cancers With Peritoneal Carcinomatosis: Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Loggie BW; Thomas P
Oncology (Williston Park); 2015 Jul; 29(7):515-21. PubMed ID: 26178339
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 2 Perioperative Management Protocols and Their Influence on Postoperative Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Standard Parenteral Nutrition, Selective Bowel Decontamination and Suprapubic Catheters?
Elekonawo FMK; van der Meeren MMD; Simkens GA; de Wilt JHW; de Hingh IH; Bremers AJA
Dig Surg; 2019; 36(5):394-401. PubMed ID: 29982248
[TBL] [Abstract][Full Text] [Related]
18. Anesthetic management in patients undergoing hyperthermic chemotherapy.
Raspe C; Piso P; Wiesenack C; Bucher M
Curr Opin Anaesthesiol; 2012 Jun; 25(3):348-55. PubMed ID: 22517311
[TBL] [Abstract][Full Text] [Related]
19. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
[TBL] [Abstract][Full Text] [Related]
20. Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status.
Ihemelandu CU; McQuellon R; Shen P; Stewart JH; Votanopoulos K; Levine EA
Ann Surg Oncol; 2013 Oct; 20(11):3519-26. PubMed ID: 23748607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
